Am J Transplant, Volume 19, Suppl 3 Archives - Page 201 of 214 - ATC Abstracts

2019 American Transplant Congress
Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Tacrolimus Intrapatient Variability in HIV+ Kidney Transplant Recipients
M. H. Cooper, I. E. Dunne, S. A. Kuten, A. E. Cantwell, E. A. Graviss, D. T. Nguyen, M. J. Hobeika, A. O. Gaber
Houston Methodist Hospital, Houston, TX
*Purpose: High tacrolimus (FK) intra-patient variability (IPV) has been associated with inferior outcomes in solid organ transplantation. HIV+ transplant recipients have been shown to experience…
2019 American Transplant Congress
Epidemiology and Risk Factors of Early Post-Transplant Clostridium difficile Infection in Renal Transplant Recipients
M. Jorgenson¹, J. Descourouez¹, D. Yang², G. Leverson², C. Saddler², J. Smith², R. Redfield²
¹UW Health, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: To elucidate the epidemiology and peri-transplant risk of CDI*Methods: Retrospective review of adult renal transplant (RTX) recipients from 1/1/2012-12/31/2015. Primary objective was to describe…
2019 American Transplant Congress
Gender Disparity: Do Female Donors Suffer from Living Kidney Donation?
N. Ebeling¹, B. Suwelack¹, M. Burgmer², a. the SoLKiD Study Group¹
¹MED D, Universitaetsklinikum Muenster, Muenster, Germany, ²Psychosomatic medicine, Universitaetsklinikum Muenster, Muenster, Germany
*Purpose: Transplantation and optional living donation is the therapy of choice in end-stage renal disease. Due to the increase of living kidney donoration (LD), the…
2019 American Transplant Congress
Renal Pathological Findings in Living Kidney Donor Candidates with Minimal Urinary Abnormalities
H. Ahmed¹, C. Drachenberg², R. Ugarte¹, N. Costa¹, C. Cangro¹, R. N. Barth³, M. Weir¹, A. Harirain¹
¹Medicine-Nephrology, University of Maryland Medical Center, Baltimore, MD, ²Pathology, University of Maryland Medical Center, Baltimore, MD, ³Surgery, University of Maryland Medical Center, Baltimore, MD
*Purpose: With the increasing number of ESRD patients requiring transplantation and stagnant number of deceased-donor organs available, minimizing the exclusion of living donor candidates with…
2019 American Transplant Congress
Robotic Donor Nephrectomy: Is It Safe Alternative?
D. Friedman, R. Shahbazov, I. Bandler, T. Malik, Z. Acun, K. Olivera-Wright, B. Gallay, O. Pankewycz, M. Laftavi
Surgery, Upstate Medical University, Syracuse, NY
*Purpose: Robotic assisted live donor nephrectomies (RDN) have continued to gain popularity in recent years. Previous studies have shown that the outcomes of these robotic…
2019 American Transplant Congress
Causes of 30 Day Graft Loss among Shared Kidneys in the National Kidney Registry (NKR)
J. Verbesey¹, A. Thomas², M. Ronin³, D. Segev⁴, A. Waterman⁵, S. Flechner⁶, M. Cooper¹
¹Georgetown University Hospital, Washington, DC, ²University of North Carolina, Chapel Hill, NC, ³National Kidney Registry, New York, NY, ⁴Johns Hopkins University, Baltimore, MD, ⁵UCLA, Los Angeles, CA, ⁶Cleveland Clinic, Cleveland, OH
*Purpose: We have previously reported favorable 1 year graft survival of over 98% in the NKR. Many early concerns associated with organ travel, longer ischemic…
2019 American Transplant Congress
Variables Associated with Intracardiac Thrombus during Orthotopic Liver Transplant: A Retrospective Single-Center Study
M. Groose¹, J. Mezrich², L. Hammel¹
¹Department of Anesthesiology, University of Wisconsin, Madison, WI, ²Department of Surgery, University of Wisconsin, Madison, WI
*Purpose: Intracardiac thrombus (ICT) is an intraoperative complication during orthotopic liver transplantation (OLT) with high mortality. Patients with end stage liver disease have compromised coagulation…
2019 American Transplant Congress
Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients
M. Kosirog¹, P. T. Campbell¹, S. Montag², S. Connolly¹, A. Daud³, A. Das¹, S. Pine¹, D. Finn³, J. Levitsky¹, J. L. Holl⁴, D. Lloyd-Jones⁵, L. B. VanWagner⁶
¹Division of GI and Hepatology, Department of Medicine, Northwestern Medicine, Chicago, IL, ²Department of Preventive Medicine, Northwestern Medicine, Chicago, IL, ³Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁴Department of Pediatrics & Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁵Departments of Preventive Medicine and Medicine-Cardiology, Northwestern Medicine, Chicago, IL, ⁶Division of GI and Hepatology, Department of Medicine and Department of Preventive Medicine, Northwestern Medicine, Chicago, IL
*Purpose: Tobacco use is a modifiable risk factor for major adverse cardiovascular events (MACE) in liver transplant recipients (LTRs). However, data are lacking about practitioner…
2019 American Transplant Congress
Learning Curve for Living Donor Laparoscopic Left Lateral Sectionectomy
R. Hwang¹, D. von Ahrens², A. Griesemer¹, T. Kato¹, J. Emond¹, D. Cherqui³, B. Samstein²
¹Department of Surgery, Columbia University Medical Center, New York, NY, ²Department of Surgery, Weill Cornell Medicine, New York, NY, ³Department of Surgery, Paul Brousse Hospital - Université Paris Sud, Villejuif, France
*Purpose: Living donor liver transplantation (LDLT) is an important method in reducing wait list mortality. Laparoscopic hepatectomy has been investigated in order to decrease donor…
2019 American Transplant Congress
Intra-Operative Kinetics of Anti-HLA Antibodies in Simultaneous Liver-Kidney Transplantation
M. Kueht, P. Jindra, M. Cusick, N. Galvan, A. Rana, J. Goss
Baylor College of Medicine, Houston, TX
*Purpose: In simultaneous liver-kidney transplantation (SLKT) in highly-sensitized patients, donor specific anti-HLA antibodies (DSA) can be present prior to transplant leading to positive crossmatch, yet…